Authors

• Tjitske Duiveman‐de Boer
• Anna de Goede
• Gerty Schreibelt (ORCID: https://orcid.org/0000-0002-0156-8365)
• Paul Leufkens
• Willem van Eden (ORCID: https://orcid.org/0000-0003-1272-704X)
• Bouke Koeneman (ORCID: https://orcid.org/0000-0002-7224-1036)
• Jacob M. van Laar (ORCID: https://orcid.org/0000-0001-5544-5785)
• I. Jolanda M. de Vries (ORCID: https://orcid.org/0000-0002-8653-4040)
• Paco M J Welsing (ORCID: https://orcid.org/0000-0003-2361-2803)
• Arie Jan Stoppelenburg (ORCID: https://orcid.org/0000-0002-1969-6146)
• Femke Broere (ORCID: https://orcid.org/0000-0001-9343-0111)
• Laureen Lammers
• Evert-Jan Breman

Institutions

• Radboud University Nijmegen (NL)
• University of Applied Sciences Utrecht (NL)
• Utrecht University (NL)
• Radboud University Medical Center (NL)
• University Medical Center Utrecht (NL)
• FF Pharma (Netherlands) (NL)

Publication Details

Journal

BMJ Open

Published

2024-09-01

DOI

https://doi.org/10.1136/bmjopen-2023-078231

Citations

9

Primary Topic

CAR-T cell therapy research

Type

article

Field-Weighted Citation Impact

2.54

Funders

• Dutch Arthritis Society
• Arthritis Society
• ZonMw
• Radboud Universitair Medisch Centrum